• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » GOP’s Brown on looming device tax: Why?

GOP’s Brown on looming device tax: Why?

February 4, 2011 By MassDevice staff

Calling it a levy with no purpose or rationale, Sen. Scott Brown (R-Mass.) is seeking to revoke an excise tax set to be charged to medical device makers in 2013 as part of the healthcare reform law.

“A 2.3 percent tax just because?" Brown told MassDevice today after a speech at the Mass. Institute of Technology. "For some of these companies, that’s their entire net profit. That’s jobs, it’s R&D, it’s a whole list of other things. It’s not a necessary tax."

The Patient Protection and Affordable Care Act President Barack Obama signed into law last year contains a provision that would require device makers to fork over 2.3 percent of their gross U.S. revenues beginning in 2013. The levy is designed to help pay for healthcare reform and aims to raise about $20 billion over 10 years.

Brown, who campaigned against the tax as he sought the late Sen. Edward Kennedy’s seat in 2009, told us opposition to the tax is "gaining a lot of steam" inside the Beltway.

"It’s hard to say right now, but as with other bills I’ve had a tremendous amount of interest from everybody," Brown said when asked to handicap his bill’s chances of passing.

Should the bid fail, he added, "I’m open to all suggestions, because the bottom line is it’s being used just because. We can do better than that."

It’s not Brown’s first bid to overturn the tax. An amendment he introduced last year during the contentious debate over healthcare reform failed to pass muster, but Brown vowed not to give up the fight.

Yesterday, Boston Scientific Corp. (NYSE:BSX) CEO Ray Elliott praised Brown for his stand against the device tax.

“Repealing this onerous tax would help the US maintain global leadership in the development, manufacturing and export of medical technology,” Elliott said.

Other moves to repeal the tax are also afoot in Washington. Republicans in the House and Senate, including Sen. Orrin Hatch of Utah, introduced a trio of bills to shoot it down in late January. Brown was a co-signer of the Hatch bill.

His solo bill aims to repeal the tax without adding to the huge federal deficit by rescinding $39 billion in appropriated discretionary funds. Brown’s measure would give the director of the federal Office of Management and Budget final say over which discretionary funds to tap, excluding cash earmarked for the U.S. Dept. of Defense or the Dept. of Veterans Affairs.

"Sen. Scott Brown" image above by Mark Sardella acquired on Flickr.

Filed Under: Healthcare Reform, News Well

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy